ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

30,959Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 168

$1.84M Total Retail Price of All Prescriptions

Rank: 1 out of 168

541 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 541 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

3% of this provider’s 541 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 25,976 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $84 among peers.

Prescriptions per Patient

57 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
WARFARIN SODIUM 1,762 1,359 1 6
SIMVASTATIN 1,382 1,194 2 1
LEVOTHYROXINE SODIUM 1,110 972 3 5
FUROSEMIDE 938 873 4 7
LISINOPRIL 896 766 5 2
TRAZODONE HCL 878 803 6 10
METOPROLOL TARTRATE 763 701 7 9
CITALOPRAM HBR 637 542 8 13
OLANZAPINE 580 471 9 39
DIVALPROEX SODIUM 577 451 10 51
MIRTAZAPINE 532 463 11 33
DONEPEZIL HCL 522 517 12 29
AMLODIPINE BESYLATE 503 465 13 4
METFORMIN HCL 488 435 14 18
OMEPRAZOLE 487 437 15 3
METOPROLOL SUCCINATE 475 413 16 12
GABAPENTIN 458 327 17 15
QUETIAPINE FUMARATE 409 347 18 21
CLOZAPINE 407 114 19 19
NAMENDA 373 369 20 42
RISPERIDONE 367 302 21 25
POTASSIUM CHLORIDE 339 315 22 83
SERTRALINE HCL 319 269 23 23
ALLOPURINOL 313 313 24 45
LANTUS 280 227 25 78
HYDROCHLOROTHIAZIDE 266 247 26 11
LACTULOSE 254 180 27 140
TAMSULOSIN HCL 243 207 28 20
LOVASTATIN 240 168 29 92
TRAMADOL HCL 238 203 30 40
LEVETIRACETAM 230 165 31 43
ALENDRONATE SODIUM 230 215 31 32
ATENOLOL 225 198 33 8
RANITIDINE HCL 220 195 34 54
LIDODERM 209 193 35 91
ATORVASTATIN CALCIUM 192 159 36 16
POLYETHYLENE GLYCOL 3350 191 132 37 108
NOVOLOG 170 120 38 139
SEROQUEL 167 138 39 70
JANUVIA 165 151 40 104
FAMOTIDINE 164 128 41 170
FLUOXETINE HCL 151 106 42 26
CARBIDOPA-LEVODOPA 150 129 43 57
ADVAIR DISKUS 150 140 43 76
DIGOXIN 149 136 45 56
ABILIFY 149 110 45 35
IPRATROPIUM-ALBUTEROL 146 125 47 181
BENZTROPINE MESYLATE 145 118 R 48 47
ISOSORBIDE MONONITRATE ER 138 121 49 64
DIVALPROEX SODIUM ER 133 119 50 69
CLOPIDOGREL 132 116 51 77
ESCITALOPRAM OXALATE 121 113 52 161
FINASTERIDE 120 105 53 27
CARBAMAZEPINE 120 51 53 106
NIFEDIPINE ER 114 108 55 82
SPIRIVA 113 108 56 131
PREDNISONE 111 107 57 31
SPIRONOLACTONE 111 101 57 156
LEVOFLOXACIN 111 102 57 207
FENOFIBRATE 110 89 60 128
HYDROCODONE-ACETAMINOPHEN 106 106 S3 61 22
FLUTICASONE PROPIONATE 104 79 62 30
CRESTOR 103 82 63 87
VALPROIC ACID 101 82 64 211
PLAVIX 100 87 65 109
HALOPERIDOL 96 63 66 99
OXYBUTYNIN CHLORIDE 94 70 67 130
TOPIRAMATE 93 67 68 52
BUPROPION HCL SR 92 78 69 41
NOVOLIN R 92 77 69 215
OXYBUTYNIN CHLORIDE ER 89 83 71 88
CYMBALTA 89 86 71 60
LOSARTAN POTASSIUM 87 83 73 53
BACLOFEN 87 25 73 89
PANTOPRAZOLE SODIUM 85 70 75 74
LAMOTRIGINE 84 56 76 28
KLOR-CON M20 84 70 76 132
CIPROFLOXACIN HCL 83 74 78 46
DOXAZOSIN MESYLATE 82 78 79 144
AGGRENOX 81 69 80 225
FLUDROCORTISONE ACETATE 78 77 81 227
LATANOPROST 78 72 81 14
CEPHALEXIN 77 65 83 129
GLIPIZIDE 76 58 84 133
ENOXAPARIN SODIUM 76 30 84 229
DILTIAZEM 24HR CD 76 76 84 187
PAROXETINE HCL 74 45 87 63
CLONIDINE HCL 73 73 88 80
HUMALOG 71 53 89 148
NOVOLIN N 71 35 89 236
NITROFURANTOIN 71 70 89 236
OXCARBAZEPINE 69 50 92 86
SANTYL 68 66 93 242
PRAVASTATIN SODIUM 67 67 94 37
BETHANECHOL CHLORIDE 66 54 95 247
ERYTHROMYCIN 66 63 95 81
FLOVENT HFA 66 64 95 123
BUPROPION HCL 65 65 98 251
DETROL LA 64 46 99 252
PRADAXA 61 61 100 204
EVISTA 61 59 100 207
EXELON 61 51 100 262
DEXTROSE WITH SODIUM CHLORIDE 61 11 100 262
DIOVAN 61 61 100 50
LABETALOL HCL 59 49 105 202
TRIAMCINOLONE ACETONIDE 58 53 106 93
METOCLOPRAMIDE HCL 58 44 106 189
DILANTIN 56 51 108 204
BUSPIRONE HCL 56 56 108 100
HEPARIN SODIUM 55 36 110 279
OLANZAPINE ODT 55 44 110 279
VENLAFAXINE HCL ER 55 34 110 62
ARANESP 54 54 113 283
BRIMONIDINE TARTRATE 54 53 113 49
ENALAPRIL MALEATE 53 40 115 149
AMOX TR-POTASSIUM CLAVULANATE 53 47 115 291
NYSTATIN 52 45 117 292
ADACEL 51 44 118 301
TIMOLOL MALEATE 51 51 118 36
CALCITRIOL 50 37 120 113
MUPIROCIN 50 46 120 202
ALBUTEROL SULFATE 50 47 120 306
TERAZOSIN HCL 50 49 120 158
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.